Wed, November 16, 2022
Tue, November 15, 2022
Mon, November 14, 2022
Fri, November 11, 2022
Thu, November 10, 2022

Matthew Biegler Maintained (VOR) at Buy with Decreased Target to $18 on, Nov 14th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-18-on-nov-14th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Biegler of Oppenheimer, Maintained "Vor Biopharma Inc." (VOR) at Buy with Decreased Target from $27 to $18 on, Nov 14th, 2022.

Matthew has made no other calls on VOR in the last 4 months.



There are 3 other peers that have a rating on VOR. Out of the 3 peers that are also analyzing VOR, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Matthew


  • Carter Gould of "Barclays" Maintained at Buy with Decreased Target to $15 on, Friday, November 11th, 2022
  • Swayampakula Ramakanth of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $20 on, Monday, August 15th, 2022
  • David Nierengarten of "Wedbush" Initiated at Buy and Held Target at $18 on, Tuesday, July 26th, 2022

Publication Contributing Sources